公开(公告)号：US20240342099A1

公开(公告)日：2024-10-17

申请号：US18681845

申请日：2022-08-04

申请人： Massachusetts Institute of Technology ,  The Brigham and Women's Hospital, Inc. ,  Novo Nordisk A/S

发明人： Carlo Giovanni Traverso ,  Declan Gwynne ,  Jacob Wainer ,  Graham Arrick ,  Jesper Windum ,  Kuldeep Sanger ,  Adam Bohr ,  Brian Mouridsen ,  Nikolaj Eusebius Jakobsen ,  Morten Revsgaard Frederiksen ,  Jens Lolle Laursen ,  Ludwig Erik Aguilar

IPC分类号： A61K9/48

CPC分类号： A61K9/4808

摘要： An ingestible device may include one or more deployable limbs configured to orient the ingestible device in a desired orientation. The one or more limbs may be attached to body of the device and wrap around the device in an initial configuration (e.g., prior to deployment of the one or more limbs). The one or more limbs may be configured to deploy when exposed to a predetermined condition. Once the predetermined condition is met, the one or more limbs may extend outwards away from the body such that the one or more deployed limbs serve to orient the ingestible device.

公开(公告)号：US20240293651A1

公开(公告)日：2024-09-05

申请号：US18573470

申请日：2021-07-09

申请人： Novo Nordisk A/S

发明人： Nikolaj Eusebius Jakobsen ,  Kuldeep Sanger

IPC分类号： A61M31/00

CPC分类号： A61M31/002 ,  A61M2205/106 ,  A61M2210/1042

摘要： A capsule administering assembly (100, 100′) comprising an ingestible capsule (200, 200′) for delivery of a mixed drug product to a subject user, and a capsule accessory device (300, 300′), wherein the ingestible capsule is operable from a first attached state where the ingestible capsule (200, 200′) is coupled relative to the capsule accessory device (300, 300′), and a second detached state wherein the ingestible capsule (200, 200′) is detached from the capsule accessory device (300, 300′) to permit ingestion of the ingestible capsule. The capsule administering assembly (100, 100′) comprises a first reservoir (231) holding a first drug component (A) and a second reservoir (332, 362), the second reservoir (332, 362) holding a second drug component (B).